Classification
Product TypeIngredient
Product FormExtract
Industry PositionFood and Complementary Medicine Ingredient
Market
Artichoke extract (Cynara scolymus) in Australia is primarily positioned as a botanical ingredient used in complementary medicines and, depending on formulation and claims, potentially in food or health-food products. Australia has a small domestic globe artichoke production base concentrated in Victoria (Port Phillip Bay area), with limited cultivation reported in other states, implying limited domestic raw-material scale for extract supply. Import market access is strongly shaped by DAFF biosecurity import conditions (via BICON) and, where supplied as food for sale, imported food inspection/testing pathways. Regulatory classification (food vs therapeutic good) is a key determinant of compliance, labelling/claims, and manufacturing controls.
Market RoleImport-dependent ingredient market with domestic formulation/manufacturing; limited domestic raw-material base
Domestic RoleBotanical ingredient used in the complementary medicines supply chain; may also appear in consumer products marketed as foods where compliant
Market GrowthNot Mentioned
SeasonalityDomestic globe artichoke (raw material) is reported as seasonally available from May to November with peak production around August to October; extract availability for manufacturers depends on inventory and import cycles.
Specification
Primary VarietyGlobe artichoke (Cynara scolymus)
Physical Attributes- Commercial Australian complementary medicine products may declare the ingredient as an 'extract dry concentrate' (dry extract form) in capsule formats.
Compositional Metrics- Some Australian retail products declare an extract quantity alongside an equivalent fresh-leaf amount (e.g., dry extract concentrate with a stated fresh-leaf equivalent).
Grades- If supplied as a listed/complementary medicine in Australia, manufacturers are expected to apply GMP controls including supplier qualification and material assessment under TGA-linked PIC/S GMP guidance.
Supply Chain
Value Chain- Supplier qualification and ingredient QC (identity/spec/COA) → shipment to Australia → DAFF biosecurity and food safety screening via BICON (and IFIS referral if imported food for sale) → domestic manufacturing/packaging into finished goods (e.g., complementary medicines) → distribution via retail/e-commerce.
Freight IntensityLow
Risks
Regulatory Compliance HighMarket access can be blocked or severely disrupted if the shipment does not meet DAFF biosecurity import conditions (BICON), including cases requiring an import permit; DAFF states goods that require a permit but arrive without one may be directed for export or destroyed.Confirm the exact BICON case for the product form and intended end use (food vs dietary supplement vs medicine), secure any required import permit before dispatch, and align packaging/treatments/documentation to the published conditions.
Boundary Classification MediumRegulatory classification (food vs therapeutic good) can change obligations for claims, labelling, and manufacturing controls; artichoke (Cynara scolymus) appears as an ingredient in ARTG medicine listings, indicating active TGA-regulated usage pathways in Australia.Lock intended positioning and claims early; if supplying therapeutic goods, confirm ARTG pathway and TGA ingredient naming conventions and GMP expectations with the sponsor/manufacturer.
Food Safety MediumIf supplied as imported food for sale, consignments may be referred for IFIS inspection/testing (risk-based settings apply), and non-compliance can trigger escalated inspection rates and holding orders.Pre-validate label/composition compliance against the Australia New Zealand Food Standards Code and maintain robust batch COA/testing aligned to foreseeable IFIS hazards for botanical ingredients.
FAQ
What are the key Australian systems and laws that govern importing artichoke extract for human consumption?DAFF sets and enforces biosecurity import conditions under the Biosecurity Act 2015 using the BICON system, and manages imported food safety risks under the Imported Food Control Act 1992 through the Imported Food Inspection Scheme (IFIS). If the product is supplied as a therapeutic good (for example, a listed medicine), it must also meet TGA requirements and be included in the Australian Register of Therapeutic Goods (ARTG) before supply.
Is globe artichoke (Cynara scolymus) used in TGA-listed products in Australia?Yes. The TGA’s ARTG includes entries for products named “Globe Artichoke” that list Cynara scolymus as an ingredient, showing that globe artichoke is used in TGA-regulated medicine products in Australia.
Which customs tariff heading commonly applies to vegetable extracts like artichoke extract when importing into Australia?Vegetable saps and extracts are covered under Customs Tariff heading 1302 in Australia. Many items in the “other” category under 1302.19.90 are shown with a general duty rate of “Free,” but the correct subheading should be confirmed for the specific product composition and presentation.